Patents by Inventor Thomas R. Foubert

Thomas R. Foubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Parenteral norovirus vaccine formulations
    Patent number: 9801934
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 31, 2017
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas R. Foubert
  • VIRUS LIKE PARTICLE PURIFICATION
    Publication number: 20160317645
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Application
    Filed: May 2, 2016
    Publication date: November 3, 2016
    Inventors: Thomas S. VEDVICK, Bryan STEADMAN, Charles RICHARDSON, Thomas R. FOUBERT, Charles R. PETRIE
  • Virus like particle purification
    Patent number: 9359410
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: June 7, 2016
    Assignee: TAKEDA VACCINES INC.
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie
  • Norovirus vaccine formulations
    Patent number: 9308249
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: April 12, 2016
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • Norovirus vaccine formulations
    Patent number: 9272028
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 1, 2016
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20160008455
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 14, 2016
    Inventors: Charles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT, William T. TINO
  • PARENTERAL NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20160000899
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 7, 2016
    Inventors: Charles RICHARDSON, Thomas R. FOUBERT
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20140286994
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 25, 2014
    Inventors: Charles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT
  • VIRUS LIKE PARTICLE PURIFICATION
    Publication number: 20130344107
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Application
    Filed: June 10, 2013
    Publication date: December 26, 2013
    Inventors: THOMAS S. VEDVICK, BRYAN STEADMAN, CHARLES RICHARDSON, THOMAS R. FOUBERT, CHARLES R. PETRIE
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20130273105
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: Charles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20130273148
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: Charles RICHARDSON, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • PARENTERAL NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20130273102
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: Charles RICHARDSON, Thomas R. FOUBERT
  • Virus like particle purification
    Patent number: 8481693
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: July 9, 2013
    Assignee: Takeda Vaccines (Montana), Inc.
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie
  • Norovirus vaccine formulations
    Patent number: 8431116
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: April 30, 2013
    Assignee: Takeda Vaccines (Montana), Inc.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20120156243
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: June 16, 2010
    Publication date: June 21, 2012
    Applicant: LigoCyte Pharmaceutical
    Inventors: Charles RICHARDSON, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20120093861
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 19, 2012
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert
  • METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS
    Publication number: 20110182975
    Abstract: The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
    Type: Application
    Filed: September 18, 2008
    Publication date: July 28, 2011
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert
  • Norovirus vaccine formulations
    Patent number: 7955603
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: June 7, 2011
    Assignee: Ligocyte Pharmaceuticals, Inc.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS
    Publication number: 20100266636
    Abstract: The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
    Type: Application
    Filed: April 22, 2010
    Publication date: October 21, 2010
    Applicant: Ligocyte Pharmaceuticals, Inc.
    Inventors: Charles RICHARDSON, Thomas S. Vedvick, Thomas R. Foubert
  • VIRUS LIKE PARTICLE PURIFICATION
    Publication number: 20100150961
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Application
    Filed: March 14, 2008
    Publication date: June 17, 2010
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie